title: Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia.
abstract: In summary, recent advances in our ability to diagnose, treat, and prevent recurrences of pneumocystis pneumonia have significantly improved the clinical management of this infection, especially in HIV-1-infected individuals. As current investigations allow our therapeutic armamentarium in this disease to be strengthened even further, it is likely that pneumocystis pneumonia will pose a diminishing threat to those patients currently most susceptible to this infection.
authors: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
authors: R T
authors: RT
authors: Davey
authors: H
authors: H
authors: Masur
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D011799:Quinazolines / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects; D016597:Trimetrexate
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D016597:Trimetrexate